Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P275 Biological therapies for patients with Crohn’s disease: More options mean less surgical interventions

ECCO'20 Vienna

Year: 2020
Authors:

Y.F. Chin1, O. PUJJI2, B. Wilkinson1, S. Mohan1, M. Nnaji1, N. Yassin1

1Department of General Surgery, New Cross Hospital, Wolverhampton, UK, 2Department of General Surgery, Academic Foundation Trainee, Wolverhampton, UK

P276 Reactivation of Epstein–Barr virus and cytomegalovirus behaves differently in pathophysiology of ulcerative colitis

ECCO'20 Vienna

Year: 2020
Authors:

S. Yamada, S. Yamamoto, Y. Honzawa, Y. Hayashi, H. Kitamoto, M. Okabe, H. Seno

Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

P277 Ileo-rectal anastomosis vs. ileoanal pouch in ulcerative colitis: clinical outcome in a real-life experience

ECCO'20 Vienna

Year: 2020
Authors:

G. Sena, B. Neri, E. Lolli, E. Calabrese, G. Sica, G. Monteleone, L. Biancone

University of Rome Tor Vergata, Gastroenterology, Rome, Italy

P278 Comparison of prostaglandin E–major urinary metabolite (PGE-MUM) with faecal calprotectin and faecal immunochemical tests for determining endoscopic remission in patients with ulcerative colitis

ECCO'20 Vienna

Year: 2020
Authors:

T. Sakurai, A. Yoshihiro, M. Haruna, M. Ryosuke, M. Yuki, S. Mariko, S. Tomoko, Y. Takushi, S. Masayuki

The Jikei University School of Medicine, Gastroenterology and Hepatology, Tokyo, Japan

P279 Early detection of mucinous adenocarcinoma within fistulating peri-anal Crohn’s disease

ECCO'20 Vienna

Year: 2020
Authors:

A. Corr1, L. Reza2, P. Lung1, I. Jenkins3, A. Antoniou3, A. Latchford4, A. Wilson4, N. Arebi4, D. Burling1, J. Warusavitarne3, O. Faiz3, S. Thomas-Gibson4, A. Hart4, P. Tozer2

1St Mark’s Hospital and Academic Institute, Department of Radiology, London, UK, 2St Mark’s Hospital and Academic Institute, Fistula Research Unit, London, UK, 3St Mark’s Hospital and Academic Institute, Colorectal surgery, London, UK, 4St Mark’s Hospital and Academic Institute, Department of Gastroenterology, London, UK

P280 Sodium picosulfate low-volume and split-dosed bowel preparation facilitates endoscopic monitoring of patients with inflammatory bowel disease

ECCO'20 Vienna

Year: 2020
Authors:

K. Fasoulas, A. Katsimpeli, P. Kevrekidou, N. Kafalis, E. Stergiou, S. Bouzoukas, G. Lazaraki, D. Tzilves, K. Soufleris

Theagenion CHT, Gastroenterology, Thessaloniki, Greece

P281 A serum biomarker panel can accurately identify the presence of mucosal ulcers in patients with Crohn’s disease

ECCO'20 Vienna

Year: 2020
Authors:

A. HOLMER, B. Boland, S. Singh, J. Neill, H. Le, A. Miralles, A. Collins, W. Sandborn, P. Dulai

University of California San Diego, Department of Gastroenterology, San Diego, USA

P282 Early disease acceleration in patients with newly diagnosed Crohn’s disease in India and Israel: Insights from an East-West inception cohort

ECCO'20 Vienna

Year: 2020
Authors:

I. Goren1, H. Yanai1, P. Pal2, B. Adigopula2, S. Pendyala2, G. Ganesh2, K. Yadgar1, R. Banerjee2, I. Dotan1, The Indo-Israeli IBD GastroEnterology paRtnership, ‘TiiiGER’ project

1Rabin Medical Center, Division of Gastroenterology, Petah Tikva, Israel, 2Asian Institute of Gastroenterology, Gastroenterology, Hyderabad, India

P283 Patient-reported symptoms over a period of 14 days reliably predict endoscopic and histological disease activity in ulcerative colitis (UC)

ECCO'20 Vienna

Year: 2020
Authors:

A. Kormilitzin1, A.J. Walsh2, L. Matini2, R. Kantschuster2, M. Lepetyukh3, J. Wilson2, O. Brain2, R. Palmer2, T. Ambrose2, J. Satsangi2, S.P.L. Travis2

1Mathematical Institute, University of Oxford, Oxford, UK, 2Translational Gastroenterology Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, 3Oxford AHSN, Translational Gastroenterology Unit, Oxford, UK

P284 Disentangling fibromyalgia from spondyloarthopathy in the patient with inflammatory bowel disease

ECCO'20 Vienna

Year: 2020
Authors:

A. Variola1, E. Bertolini2, M. Di Ruscio1, F. Vernia3, A. Geccherle1, M. Beltrami2, I. Tinazzi4, P. Macchioni5

1IRCCS Sacro Cuore - Don Calabria, IBD Unit, Negrar di Valpolicella, Italy, 2Ospedale S. Maria Nuova, Gastroenterology Unit, Reggio Emilia, Italy, 3University of L’Aquila, Gastroenterology Unit, L’Aquila, Italy, 4IRCCS Sacro Cuore - Don Calabria, Rheumatology Unit, Negrar di Valpolicella, Italy, 5Ospedale S. Maria Nuova, Rheumatology Department, Reggio Emilia, Italy

P285 Is faecal immunochemical test a suitable alternative to faecal calprotectin in children?

ECCO'20 Vienna

Year: 2020
Authors:

K. SANDHU1, R. Ayling2, S. Naik1

1Royal London Hospital, Paediatric Gastroenterology, London, UK, 2Barts Health NHS Trust, Pathology, London, UK

P286 Rate of colectomy in ulcerative colitis: Results from a Spanish cohort with 15 years of follow-up

ECCO'20 Vienna

Year: 2020
Authors:

C. Rodriguez Gutiérrez1, A. Elosua Gonzalez2, C. Prieto Martínez1, S. Rubio Iturria1, M.A. Vicuña1, Ó. Nantes Castillejo1

1Complejo Hospitalario de Navarra, Gastroenterology and Hepatology, Pamplona, Spain, 2Hospital García Orcoyen, Gastroenterology and Hepatology, Estella, Spain

P287 Patient sex does not affect endoscopic outcomes of biologicals in patients with inflammatory bowel disease, but is possibly associated with adverse events: A systematic review

ECCO'20 Vienna

Year: 2020
Authors:

M.R.K.L. Lie, E. Paulides, C.J. van der Woude

Department of Gastroenterology and Hepatology, ErasmusMC, Rotterdam, The Netherlands

P288 Gut barrier failure biomarkers in IBD: Is there anything new beyond „The Wall’?

ECCO'20 Vienna

Year: 2020
Authors:

N. Sipeki MD1, P. Kovats1, B. Balogh1, Z. Shums2, G.L. Norman2, P. Antal-Szalmas3, M. Papp1

1Division of Gastroenterology, Department of Internal Medicine, University of Debrecen, Debrecen, Hungary, 2Inova Diagnostics, Inc., San Diego, USA, 3Department of Laboratory Medicine, University of Debrecen, Debrecen, Hungary

P289 Biological therapies and the trajectories of biopsychological factors in inflammatory bowel diseases

ECCO'20 Vienna

Year: 2020
Authors:

P. Tavakoli1, U. Vollmer-Conna2, X. Vazquez Campos3, D. Hadzi-Pavlovic2, M. Grimm1

1Faculty of Medicine-St George and Sutherland Clinical School, UNSW Sydney Australia, Sydney, Australia, 2School of Psychiatry, UNSW Sydney Australia, Sydney, Australia, 3School of Biotechnology and Biomolecular Sciences, UNSW Sydney Australia, Sydney, Australia

P290 Long-term disease outcome of ulcerative colitis (UC) in South Ostrobothnia, Finland with a follow-up time of 25 years

ECCO'20 Vienna

Year: 2020
Authors:

K. Kontola1, P. Oksanen2, H. Huhtala3, H. Tunturi-Hihnala1, A. Jussila4

1The Research Group of Gastrointestinal Disorders, 1The Hospital District of South OstroBothnia, Internal Medicine, Seinäjoki, Finland, 2Tampere University- Tampere University Hospital, Department of Gastroenterology and Alimentary Tract Surgery, Tampere, Finland, 3Tampere University, Faculty of Social Sciences, Tampere, Finland, 4Tampere University Hospital, Department of Gastroenterology and Alimentary Tract Surgery, Tampere, Finland

P291 Diagnostic utility of the neutrophil-platelet rate (NeuPla) as a marker of activity in patients with ulcerative colitis

ECCO'20 Vienna

Year: 2020
Authors:

J.K. Yamamoto-Furusho MD- PhD1, E.A. Mendieta-Escalante2

1National Institute of Medical Science and Nutrition Salvador Zubiran, Department of Gastroenterology, Mexico City, Mexico, 2IBD Clinic- Department of Gastroenterology, Instituto Nacional de Ciencias Medicas y Nutrition, Gastroenterology, Mexico, Mexico

P292 Inflammatory bowel disease and their implications in Roma ethnicity: A preliminary study

ECCO'20 Vienna

Year: 2020
Authors:

B. Castro1, M.J. García García1, M. Pascual1, J.L. Fernández-Forcelledo2, J. Crespo1, M. Rivero1

1Marqués de Valdecilla University Hospital, Gastroenterology, Santander- Cantabria, Spain, 2Sierrallana Hospital, Gastroenterology, Torrelavega-Cantabria, Spain

P293 Loss of response after first-line biologic therapy in patients with inflammatory bowel disease: practical approach and management

ECCO'20 Vienna

Year: 2020
Authors:

A. Busacca, B. Scrivo, E. Giuffrida, L. Guida, L. Carrozza, V. Calvaruso, M. Cappello

Gastroenterology and Hepatology Section, PROMISE, University of Palermo, Palermo, Italy

P294 Clinic features and the prognosis of colonic Crohn’s disease

ECCO'20 Vienna

Year: 2020
Authors:

D. Ozgur1, A.I. Hatemi2, Y. Erzin2, A. Çelik2

1Department of Internal Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey, 2Department of Gastroenterology, Istanbul University-Cerrahpasa, Istanbul, Turkey